Amneal Pharmaceuticals, Inc. AMRX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s investing cash flow?
- Amneal Pharmaceuticals, Inc. (AMRX) reported investing cash flow of -$21.71M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s investing cash flow decreased by 22.0% year-over-year, from -$17.8M to -$21.71M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s investing cash flow has grown at a -12.8% compound annual growth rate (CAGR), from -$194.18M to -$112.26M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.